App-Quantinova.ai

ENDOCANNABINOID SYSTEM AND SYSTEMIC LUPUS ERYTHEMATOSUS

L. Navarini - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

HYDROXYCHLOROQUINE RETINOPATHY: UPDATE ON APPLICATION OF THE 2011 SCREENING GUIDELINES IN AN ACADEMIC PRACTICE

S.M.A. Shah - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetic retinopathy

Hydroxychloroquine

ULTRASOUND MEASURES OF SYNOVITIS ARE INDEPENDENT OF CLINICAL PARAMETERS IN THE SETTING OF RHEUMATOID ARTHRITIS REMISSION: A CROSS-SECTIONAL ANALYSIS

K.F. Baker - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Hydroxychloroquine

ASSOCIATION BETWEEN USE OF DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS AND DIABETES IN PATIENTS WITH ANKYLOSING SPONDYLITIS, RHEUMATOID ARTHRITIS, OR PSORIASIS/PSORIATIC ARTHRITIS: NATIONWIDE, POPULATION-BASED COHORT STUDY OF 84,989 PATIENTS

H.H. Chen - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Ankylosing spondylitis

Hydroxychloroquine

EPIDEMIOLOGY AND OUTCOME OF DERMATOMYOSITIS IN NORTHWESTERN THRACE REGION IN TURKEY

M.A. Balci - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Chronic obstructive pulmonary disease

Hydroxychloroquine

DEMOGRAPHIC, CLINIC AND LABORATORY FEATURES OF 755 PATIENTS WITH NEONATAL LUPUS ERYTHEMATOSUS: SYSTEMATIC REVIEW

A. Erden - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Hydroxychloroquine

NOVEL Sjogren's AUTOANTIBODIES FOUND IN FIBROMYALGIA PATIENTS WITH SICCA AND/OR XEROSTOMIA

A. Lichtbroun - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Dental and Oral Health

Fibromyalgia

Hydroxychloroquine

WHIPPL-S DISEASE MIMICKING RHEUMATOID ARTHRITIS LEADS TO MISDIAGNOSIS, TREATMENT FAILURE, AND PROLONGED DISEASE COURSE: A SINGLE-CENTER CASE SERIES OF SEVEN PATIENTS

C. Glaser - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Inflammatory Arthritis

Hydroxychloroquine

NANOMEDICINE APPROACHES IN RHEUMATOLOGY

B. Sarmento - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Rheumatoid arthritis

Hydroxychloroquine

TELEPHONE FOLLOW-UP, STANDARDIZED TO THE INITIATION OF BIOLOGIC THERAPY OF PATIENTS WITH RHEUMATOID ARTHRITIS (RA) IN A SPECIFIC UNIT OF BIOLOGIC THERAPY. PILOT STUDY

L. Cano-Garcia - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Urinary tract infections

Hydroxychloroquine

MUSCULOSKELETAL SARCOIDOSIS- DEMOGRAPHICS, CLINICAL CHARACTERISTICS, AND TREATMENT EXPERIENCE FROM A TERTIARY CARE CENTER IN THE UNITED STATES

M. Arakane - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Sarcoidosis

Hydroxychloroquine

PANNICULITIS IN RHEUMATOLOGY PRACTICE: RESULTS OF LONG-TERM FOLLOW UP

N.M. Savushkina - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Congestive heart failure

Hydroxychloroquine

INFERTILITY AND PREGNANCY IN RHEUMATIC DISEASES: THE UTILITY OF A MULTIDISCIPLINARY PROTOCOL FOR THE MANAGEMENT OF THESE PATIENTS

I.C. Chalmeta - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Familial Mediterranean fever

Hydroxychloroquine

UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE: A 121 PATIENTS AUDIT FOCUSING ON INITIAL DIAGNOSIS AND CHANGES OVER TIME

R. Ionescu - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Idiopathic pulmonary fibrosis

Hydroxychloroquine

PREGNANCY IN PATIENTS WITH UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE: CLINICAL OUTCOMES IN 78 CASES

R. Vagelli - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Spontaneous preterm delivery

Hydroxychloroquine

CYCLOSPORINE IN RESISTANT SYSTEMIC JIA - A CHEAPER ALTERNATIVE TO BIOLOGICS FOR DEVELOPING COUNTRIES

P.P. Giri - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Hydroxychloroquine

TRANSITIONAL CARE UNIT FOR PATIENTS WITH PEDIATRIC-ONSET RHEUMATIC DISEASES: 4 YEARS EXPERIENCE IN A SPANISH TERTIARY HOSPITAL

W.A. Sifuentes Giraldo - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Hydroxychloroquine

FIVE YEAR OUTCOMES OF REMISSION STEERED TREATMENT INCLUDING DRUG TAPERING STRATEGIES IN EARLY ARTHRITIS PATIENTS

G. Akdemir - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Hydroxychloroquine

COMPARISON OF THE EFFICACY AND TOLERANCE OF THE TRIPLE ORAL THERAPY VERSUS ANTI-TNF PLUS METHOTREXATE IN RHEUMATOID ARTHRITIS WITH INADEQUATE RESPONSE TO METHOTREXATE: A SYSTEMATIC LITERATURE REVIEW

J. Mary - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Hydroxychloroquine

EXCELLENT OUTCOMES SUSTAINED EVEN IN LONG-TERM WHEN TARGETED TREATMENT WITH A COMBINATION OF TRADITIONAL DMARDS IS USED IN EARLY RHEUMATOID ARTHRITIS. THE 10-YEAR FOLLOW-UP RESULTS OF A RANDOMIZED CLINICAL TRIAL, THE NEO-RACO TRIAL

V. Rantalaiho - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Hydroxychloroquine

Filters

1151 Abstracts